Trade Mark Journal No.2026/042 16 October 2026

WO0000001940261 (42)

Office of origin: United States of America

Date of International Registration:29 May 2026
Date of designation in the UK: 29 May 2026
Image for mark 1940261 RESOLV

International priority date claimed: 1 December 2025 (United States of America) (99523753)
Class 42
Medical research services for measuring positive predictive value for cancer screening and for high resolution cancer screening and risk stratification; providing temporary use of on-line non-downloadable software featuring machine learning and AI for analyzing positive predictive value for cancer; providing temporary use of on-line non-downloadable software featuring machine learning and AI for high resolution cancer screening and risk stratification.

Harbinger Health, Inc.

Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA